| Coronary
Risk Evaluation in Patients With Transient Ischemic Attack and Ischemic
Stroke Circulation. 2003;108:1278-1290 Commento redatto da SEFAP - Servizio di Epidemiologia e Farmacologia Preventiva (www.sefap.it) E' disponibile un set di diapositive su Ictus ed eventi cardiovascolari Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 2003; 42:1206 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension Journal of Hypertension 2003, 21:1011–1053 Commento redatto da SEFAP - Servizio di Epidemiologia e Farmacologia Preventiva (www.sefap.it) U.S. Department of Health and Human Services: Settimo rapporto del Joint National Committe linee-guida per l'ipertensione arteriosa JAMA 2003; 289:2560-71 Commento redatto da SEFAP - Servizio di Epidemiologia e Farmacologia Preventiva (www.sefap.it) ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina - Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina) Circulation 2003; 107:149-158 Linee-guida
nel trattamento delle dislipidemie e degli altri fattori di rischio cardiovascolare Prevenzione
della malattia coronarica nella pratica clinica. Coronary
Heart Disease: Reducing the Risk. Primary
Prevention Of Coronary Heart Disease: Guidance from Framingham. Beyond
Secondary Prevention: Identifying the High Risk Patient for Primary Prevention Detection,
Evalutation, and Treatment of High Blood Cholesterol in Audults (Adult
Treatment Panel III - ATP III)
Linee guida 1999 per il trattamento dell’ipertensione arteriosa dell'Organizzazione
Mondiale della Sanità e della Società Internazionale dell’Ipertensione American
Diabetes Association: Clinical Practice Recommendations 2001. Linee
guida per la refertazione in biochimica-clinica dei livelli plasmatici
dei lipidi e lipoproteine AHA/ACC
Guideliness for Preventing Haert Attack and Death in Patients With Atherosclerotic
Cardiovascular Disease: 2001 Update |